Total Valuation
Vycor Medical has a market cap or net worth of $2.30M. The enterprise value is $3.03M.
Market Cap$2.30M
Enterprise Value$3.03M
Share Statistics
Vycor Medical has 33,372,795 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,372,795
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vycor Medical’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is -1.10%.
Return on Equity (ROE)0.02
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-1.10%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee266.20K
Profits Per Employee-10.35K
Employee Count7
Asset Turnover2.24
Inventory Turnover2.27
Valuation Ratios
The current PE Ratio of Vycor Medical is ―. Vycor Medical’s PEG ratio is -0.04.
PE Ratio―
PS Ratio2.17
PB Ratio-0.99
Price to Fair Value-0.99
Price to FCF-216.00
Price to Operating Cash Flow20.40
PEG Ratio-0.04
Income Statement
In the last 12 months, Vycor Medical had revenue of 1.86M and earned -72.43K in profits. Earnings per share was -0.01.
Revenue1.86M
Gross Profit1.50M
Operating Income33.90K
Pretax Income-70.19K
Net Income-72.43K
EBITDA96.53K
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 112.86K and capital expenditures -5.22K, giving a free cash flow of 107.63K billion.
Operating Cash Flow112.86K
Free Cash Flow107.63K
Free Cash Flow per Share<0.01
Dividends & Yields
Vycor Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change-33.01%
50-Day Moving Average0.06
200-Day Moving Average0.11
Relative Strength Index (RSI)69.83
Average Volume (3m)2.94K
Important Dates
Vycor Medical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Vycor Medical as a current ratio of 0.12, with Debt / Equity ratio of -23.19%
Current Ratio0.12
Quick Ratio0.08
Debt to Market Cap0.24
Net Debt to EBITDA9.54
Interest Coverage Ratio0.33
Taxes
In the past 12 months, Vycor Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Vycor Medical EV to EBITDA ratio is 51.38, with an EV/FCF ratio of -265.29.
EV to Sales2.66
EV to EBITDA51.38
EV to Free Cash Flow-265.29
EV to Operating Cash Flow-368.16
Balance Sheet
Vycor Medical has $173.63K in cash and marketable securities with $980.81K in debt, giving a net cash position of -$807.18K billion.
Cash & Marketable Securities$173.63K
Total Debt$980.81K
Net Cash-$807.18K
Net Cash Per Share-$0.02
Tangible Book Value Per Share-$0.12
Margins
Gross margin is 82.93%, with operating margin of 1.82%, and net profit margin of -3.89%.
Gross Margin82.93%
Operating Margin1.82%
Pretax Margin-3.77%
Net Profit Margin-3.89%
EBITDA Margin5.18%
EBIT Margin1.79%
Analyst Forecast
The average price target for Vycor Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.66%
EPS Growth Forecast24.06%